Institutional investors hold a majority ownership of ZTS through the 95.46% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2016, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 6.4 Million shares of Zoetis Inc
EATON VANCE MANAGEMENT Bought 2.9 Million shares of Zoetis Inc
AMERICAN CENTURY INVESTMENT MANA... Bought 1.9 Million shares of Zoetis Inc